With multi-bln dollar investment, AstraZeneca reaffirms confidence in China: CEO
BEIJING, Jan. 31 (Xinhua) -- China has become a critical contributor to scientific innovation and advanced manufacturing, as well as a driving force for common prosperity worldwide, Pascal Soriot, CEO of British pharmaceutical giant AstraZeneca, told Xinhua on Friday.
Soriot made the remarks in an interview in Beijing, a day after the firm pledged to invest 15 billion U.S. dollars in China through 2030 to expand